These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8637410)

  • 1. Endothelins and endothelin receptor antagonists: binding to plasma proteins.
    Wu-Wong JR; Chiou WJ; Hoffman DJ; Winn M; von Geldern TW; Opgenorth TJ
    Life Sci; 1996; 58(21):1839-47. PubMed ID: 8637410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonists: effect of serum albumin on potency and comparison of pharmacological characteristics.
    Wu-Wong JR; Dixon DB; Chiou WJ; Opgenorth TJ
    J Pharmacol Exp Ther; 1997 May; 281(2):791-8. PubMed ID: 9152387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human plasma proteins on endothelin binding and function.
    Wu-Wong JR; Dixon DB; Opgenorth TJ
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S164-8. PubMed ID: 9595428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of diminishing albumin binding to some Endothelin receptor antagonists.
    Szczepankiewicz BG; Bal RB; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Opgenorth TJ; Hoffman DJ; Borre AJ; Marsh KC; Nguyen BN
    Life Sci; 1998; 63(21):1905-12. PubMed ID: 9825768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist.
    Wu-Wong JR; Chiou WJ; Naugles KE; Opgenorth TJ
    Life Sci; 1994; 54(22):1727-34. PubMed ID: 8177014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
    Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
    Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
    Wu-Wong JR; Chiou WJ; Magnuson SR; Opgenorth TJ
    Biochim Biophys Acta; 1994 Nov; 1224(2):288-94. PubMed ID: 7981244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for assessing endothelin ETA-receptor antagonists in preclinical studies.
    Okada M; Siegl PK; Nishikibe M
    Methods Find Exp Clin Pharmacol; 2002; 24(6):361-70. PubMed ID: 12224443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig.
    Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E
    Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist.
    Williams DL; Murphy KL; Nolan NA; O'Brien JA; Lis EV; Pettibone DJ; Clineschmidt BV; Krause SM; Veber DF; Naylor EM; Chakravarty PK; Walsh TF; Dhanoa DM; Chen A; Bagley SW; Fitch KJ; Greenlee WJ
    Life Sci; 1996; 58(14):1149-57. PubMed ID: 8614266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.
    Nambi P; Elshourbagy N; Wu HL; Pullen M; Ohlstein EH; Brooks DP; Lago MA; Elliott JD; Gleason JG; Ruffolo RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):755-61. PubMed ID: 7965793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan.
    Adachi M; Furuichi Y; Miyamoto C
    Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats.
    Filep JG
    Br J Pharmacol; 2000 Mar; 129(5):975-83. PubMed ID: 10696098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of a novel non-peptide endothelin receptor antagonist (bosentan) in rat liver and vasculature.
    Phillips PA; Risvanis J; Aldred K; Burrell LM; Bartholomeusz B
    Clin Sci (Lond); 1995 Dec; 89(6):575-9. PubMed ID: 8549075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of endothelin to plasma proteins and tissue receptors: effects on endothelin determination, vasoactivity, and tissue kinetics.
    Brunner F; Stessel H; Watzinger N; Löffler BM; Opie LH
    FEBS Lett; 1995 Oct; 373(1):97-101. PubMed ID: 7589443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
    Clozel M; Breu V; Gray GA; Kalina B; Löffler BM; Burri K; Cassal JM; Hirth G; Müller M; Neidhart W
    J Pharmacol Exp Ther; 1994 Jul; 270(1):228-35. PubMed ID: 8035319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
    Simonson MS; Rooney A
    Mol Pharmacol; 1994 Jul; 46(1):41-50. PubMed ID: 8058055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.